Abstract
How to construct protein chips and chemically labeling drug molecules without disrupting structures for HTS is still a challenging area. There are two main obstacles, one is that human multitrans membrane receptors, which are major drug targets, exhibit distinct motifs, and fold structures, and they will collapse unfold without membrane support in vitro; another one is that there still lack effective chemical labeling method for small drugs for detection. Therefore, how to acquire high detecting sensitivity for small molecules and to immobilize membrane protein receptors in native conformation with uniform direction on the chip, need to be solved for drug HTS. This paper reviews drug HTS trends in recent years, proposed a new virion-chip model and a feasible C-H activation method for CY-5 labeling drugs. It is expected to provide a good platform for future drug HTS.
Keywords: C-H activation, detecting sensitivity, human multi-trans membrane protein, native conformation, small drugs, Virion-chip.
Mini-Reviews in Medicinal Chemistry
Title:The Development of Protein Chips for High Throughput Screening (HTS) of Chemically Labeling Small Molecular Drugs
Volume: 16 Issue: 10
Author(s): Yingzhu Feng, Bochu Wang, Xinxin Chu, Yazhou Wang and Liancai Zhu
Affiliation:
Keywords: C-H activation, detecting sensitivity, human multi-trans membrane protein, native conformation, small drugs, Virion-chip.
Abstract: How to construct protein chips and chemically labeling drug molecules without disrupting structures for HTS is still a challenging area. There are two main obstacles, one is that human multitrans membrane receptors, which are major drug targets, exhibit distinct motifs, and fold structures, and they will collapse unfold without membrane support in vitro; another one is that there still lack effective chemical labeling method for small drugs for detection. Therefore, how to acquire high detecting sensitivity for small molecules and to immobilize membrane protein receptors in native conformation with uniform direction on the chip, need to be solved for drug HTS. This paper reviews drug HTS trends in recent years, proposed a new virion-chip model and a feasible C-H activation method for CY-5 labeling drugs. It is expected to provide a good platform for future drug HTS.
Export Options
About this article
Cite this article as:
Feng Yingzhu, Wang Bochu, Chu Xinxin, Wang Yazhou and Zhu Liancai, The Development of Protein Chips for High Throughput Screening (HTS) of Chemically Labeling Small Molecular Drugs, Mini-Reviews in Medicinal Chemistry 2016; 16 (10) . https://dx.doi.org/10.2174/1389557515666150511152922
DOI https://dx.doi.org/10.2174/1389557515666150511152922 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Liposomes: A Review of Manufacturing Techniques and Targeting Strategies
Current Nanoscience The Polymorphisms of DNA G-Quadruplex Investigated by Docking Experiments with Telomestatin Enantiomers
Current Pharmaceutical Design A Facile, Microwave-Assisted Synthesis of an Adenosine-Ribose Probe for Binding-Based Profiling of Nucleoside and Nucleotide-Binding Proteins
Current Microwave Chemistry Pharmacogenetics of Irinotecan
Current Medicinal Chemistry - Anti-Cancer Agents Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Mouse Melanoma B16F10 Cells
Recent Patents on Anti-Cancer Drug Discovery Eco-friendly Synthesis of Pyrido[2,3-d]pyrimidine Analogs and Their Anticancer and Tyrosine Kinase Inhibition Activities
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Anticancer Properties of Novel Truncated Carbocyclic Nucleoside Analogues
Anti-Cancer Agents in Medicinal Chemistry Novel Stereoselective Oximes: Their Synthesis and Anti-leishmanials Evaluation
Current Bioactive Compounds <i>Arctium Lappa</i> and Management of Liver Functions to Detoxify the Bloodstream
The Natural Products Journal Synergistic Activity of the c-Met and Tubulin Inhibitor Tivantinib (ARQ197) with Pemetrexed in Mesothelioma Cells
Current Drug Targets Development of a Reproducible, Sensitive and Rapid Reversed Phase Chromatographic Method for the Estimation of Isotretinoin Incorporated in Bulk Drugs, Pharmaceutical Dosage Forms and Biological Matrix
Current Pharmaceutical Analysis The Role of Proteomics in Osteoarthritis Pathogenesis Research
Current Drug Targets Beneficial Effect of Peptides from Microalgae on Anticancer
Current Protein & Peptide Science Microemulsions for Colorectal Cancer Treatments. General Considerations and Formulation of Methotrexate
Mini-Reviews in Medicinal Chemistry Subtype Classification by Polymerase and Gag Genes of HIV-1 Iranian Sequences Registered in the NCBI GenBank
Current Proteomics GPCR Drug Discovery: Novel Ligands for CNS Receptors
Recent Patents on CNS Drug Discovery (Discontinued) Development of Heparanase Inhibitors for Anti-Cancer Therapy
Current Medicinal Chemistry Carbohydrate Microarray Technology for Functional Glycomics
Current Chemical Biology Architecture and Conservation of the Bacterial DNA Replication Machinery, an Underexploited Drug Target
Current Drug Targets Advances and Challenges in the Synthesis of Highly Oxidised Natural Phenols with Antiviral, Antioxidant and Cytotoxic Activities
Current Medicinal Chemistry